Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 10/20 | 0.46 |
| ▸ | CNR1 | P21554 | 5/20 | 0.43 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.42 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.41 |
| ▸ | RHEB | Q15382 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL544317 | 0.91 | CNR1 (0.49) | PTGER1CNR1MRGPRX4MGAMGAA | |
| SCHEMBL2492027 | 0.90 | CSNK2A2 (0.41) | CNR1MRGPRX4RHEB | |
| SCHEMBL4037797 | 0.87 | PTGER1 (0.48) | PTGER1MRGPRX4MGAMGAASI | |
| SCHEMBL4037697 | 0.86 | PTGER1 (0.50) | PTGER1MRGPRX4MGAMGAASI | |
| SCHEMBL4037851 | 0.83 | PTGER1 (0.47) | PTGER1MRGPRX4MGAMGAASI | |
| SCHEMBL4038959 | 0.83 | PTGER1 (0.48) | PTGER1MRGPRX4MGAMGAASI | |
| SCHEMBL544396 | 0.82 | PTGER1 (0.44) | PTGER1CNR1MRGPRX4MGAMGAA | |
| SCHEMBL4036485 | 0.82 | PTGER1 (0.47) | PTGER1MRGPRX4MGAMGAASI | |
| SCHEMBL913599 | 0.82 | PAICS (0.41) | — | |
| SCHEMBL913482 | 0.82 | CNR1 (0.40) | CNR1MRGPRX4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2439193-B1 | Derivatives of 5,6-bisaryl-2-pyridine-carboxamide, preparation and use thereof in therapeutics as antagonists of urotensin II receptors | SANOFI SA (FR) | 2014-04-23 | — | — | EP | disclosed |
| EP-2059508-B1 | 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS | SANOFI SA (FR) | 2012-04-11 | — | — | EP | disclosed |
| EP-2059508-A1 | 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS | Sanofi-Aventis (FR) | 2009-05-20 | — | — | EP | disclosed |
| WO-2008020124-A1 | 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS | SANOFI-AVENTIS (FR) | 2008-02-21 | — | — | WO | disclosed |